TP53 and cervical carcinoma: Yet, Niibe et al (1999) reported that the number of p21- and p53-positive cells increased after RT in tumour tissue taken before treatment and 6 h after the fifth dose of 1.8 Gy from patients with cervical cancer FIGO stage II-IVA.